Skip to main content
Top

Current Oncology Reports

Issue 3/2024

Content (10 Articles)

The Dairy and Cancer Controversy: Milking the Evidence

Taylor E. Scialo, Crystal M. Pace, Donald I. Abrams

REVIEW

Establishing an Integrative Oncology Service: Essential Aspects of Program Development

Judith Lacey, Alissa Huston, Gabriel Lopez, Julia Ruiz Vozmediano, Chun Sing Lam, Santhosshi Narayanan, Weidong Lu, Ursula Wolf, Ishwaria M. Subbiah, Patrick Richard, Ana Maria Lopez, Santosh Rao, Moshe Frenkel

Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade

Piiamaria S. Virtanen, Kyle J. Ortiz, Ajay Patel, William A. Blocher III, Angela M. Richardson

BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach

Jenna M. Menger, Ryan S. Sathianathen, Kathleen M. Sakamoto, Nobuko Hijiya

Open Access Radiotherapy REVIEW

Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway

Marion Florimond, Lucas T. Duong, Elodie Lours, Jean-Jacques Brau, François C. Ferré, Isabelle Fouilloux, Tchilalo Boukpessi

Open Access Targeted Therapy REVIEW

Integrated Molecular and Histological Insights for Targeted Therapies in Mesenchymal Sinonasal Tract Tumors

Cosima C. Hoch, Leonard Knoedler, Samuel Knoedler, Ali Bashiri Dezfouli, Benedikt Schmidl, Anskar Trill, Jennifer E. Douglas, Nithin D. Adappa, Fabian Stögbauer, Barbara Wollenberg

Open Access Respiratory Microbiota REVIEW

Current Trends and Challenges of Microbiome Research in Bladder Cancer

Ilaha Isali, Emma K. Helstrom, Nicole Uzzo, Ankita Lakshmanan, Devika Nandwana, Henkel Valentine, Mohit Sindhani, Philip Abbosh, Laura Bukavina

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine